We also showed that the shortest isoforms of CD44, so called CD44s, which does not contain any sequences encoded by alternatively spliced variant exons, was sufficient to confer resistance to doxorubicin in osteosarcoma cells (Figure 2). The gene discussed is CD44; the disease is osteosarcoma.